Opium and Cigarette Smoking are Independently Associated with Bladder Cancer: The Findings of a Matched Case - Control Study.


Journal

Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625

Informations de publication

Date de publication:
01 Oct 2021
Historique:
received: 20 07 2021
entrez: 29 10 2021
pubmed: 30 10 2021
medline: 5 2 2022
Statut: epublish

Résumé

Bladder cancer disproportionally affects the communities. While it is the ninth most common cancer in the world, in some parts of Iran including Kerman province it is the most common cancer among men. This study aimed to determine potential risk factors of bladder cancer in Kerman province, Iran. During February to July 2020, in this matched hospital-based case-control study, 100 patients with bladder cancer and 200 healthy individuals (matched in age and sex) were recruited. Socio-demographics status, occupational exposures, common diet, history of drug use and family history of cancer, were collected using a structured questionnaire. Bivariable and multivariable logistic regression were applied and crude and adjusted odds ratios (AOR) along with their 95% confidence intervals (95%CI) were calculated. Data were analyzed using Stata version 14 software. Opium consumption, cigarette smoking and low level of income were associated with increased chance of bladder cancer. Compared to never use, use of opium up to 18000 Gram -year was associated with increased chance of bladder cancer (AOR: 6; 95% CI =2.3, 15.5). The chance was higher among those who used opium more than 18,000 Gram - year (AOR: 11.3; 95% CI =2.3, 15.5). In comparison with never smokers, the chance of bladder cancer increased among those who smoked up to 20 pack-year cigarette) (AOR: 3.4; 95%CI= 1.3, 8.9) and those who smoke ≥ 20 pack-year (AOR: 15.8; 95% CI= 5.9, 42.4). The observed strong dose-response association between opium consumption, cigarette smoking and bladder cancer highlights the need for extension of harm reduction programs especially in regions with high burden of disease.

Sections du résumé

BACKGROUND BACKGROUND
Bladder cancer disproportionally affects the communities. While it is the ninth most common cancer in the world, in some parts of Iran including Kerman province it is the most common cancer among men. This study aimed to determine potential risk factors of bladder cancer in Kerman province, Iran.
METHODS METHODS
During February to July 2020, in this matched hospital-based case-control study, 100 patients with bladder cancer and 200 healthy individuals (matched in age and sex) were recruited. Socio-demographics status, occupational exposures, common diet, history of drug use and family history of cancer, were collected using a structured questionnaire. Bivariable and multivariable logistic regression were applied and crude and adjusted odds ratios (AOR) along with their 95% confidence intervals (95%CI) were calculated. Data were analyzed using Stata version 14 software.
RESULTS RESULTS
Opium consumption, cigarette smoking and low level of income were associated with increased chance of bladder cancer. Compared to never use, use of opium up to 18000 Gram -year was associated with increased chance of bladder cancer (AOR: 6; 95% CI =2.3, 15.5). The chance was higher among those who used opium more than 18,000 Gram - year (AOR: 11.3; 95% CI =2.3, 15.5). In comparison with never smokers, the chance of bladder cancer increased among those who smoked up to 20 pack-year cigarette) (AOR: 3.4; 95%CI= 1.3, 8.9) and those who smoke ≥ 20 pack-year (AOR: 15.8; 95% CI= 5.9, 42.4).
CONCLUSIONS CONCLUSIONS
The observed strong dose-response association between opium consumption, cigarette smoking and bladder cancer highlights the need for extension of harm reduction programs especially in regions with high burden of disease.

Identifiants

pubmed: 34711016
doi: 10.31557/APJCP.2021.22.10.3385
pmc: PMC8858234
pii:
doi:

Substances chimiques

Narcotics 0
Opium 8008-60-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3385-3391

Références

Addict Health. 2016 Fall;8(4):252-260
pubmed: 28819556
CA Cancer J Clin. 2018 Nov;68(6):425-445
pubmed: 30285281
Cancer Epidemiol Biomarkers Prev. 2020 Mar;29(3):650-658
pubmed: 31915141
Asian Pac J Cancer Prev. 2013;14(8):4723-5
pubmed: 24083733
Urol Oncol. 2018 May;36(5):237.e9-237.e17
pubmed: 29338913
Sci Rep. 2018 Jan 18;8(1):1129
pubmed: 29348548
Res Rep Urol. 2020 Mar 05;12:91-103
pubmed: 32185152
Cancer Res. 2009 Sep 1;69(17):6857-64
pubmed: 19706757
Nutrients. 2018 Aug 10;10(8):
pubmed: 30103393
EClinicalMedicine. 2021 Feb 24;33:100768
pubmed: 33718852
Carcinogenesis. 1982;3(5):577-85
pubmed: 7046981
Int J Prev Med. 2015 May 20;6:42
pubmed: 26097671
Cancer Prev Res (Phila). 2017 Oct;10(10):588-597
pubmed: 28851690
Daru. 2018 Sep;26(1):77-83
pubmed: 30159760
Eur Urol Focus. 2015 Aug;1(1):17-27
pubmed: 28723350
Asian Pac J Cancer Prev. 2018 Jun 25;19(6):1533-1541
pubmed: 29936728
Carcinogenesis. 1983;4(2):227-30
pubmed: 6825211
Int J Epidemiol. 2016 Jun;45(3):792-805
pubmed: 26411407
Jpn J Clin Oncol. 2016 Mar;46(3):273-83
pubmed: 26941372
Asian Pac J Cancer Prev. 2012;13(10):5053-6
pubmed: 23244109
Int J Drug Policy. 2016 May;31:147-52
pubmed: 26980349

Auteurs

Zahra Abdolahinia (Z)

HIV/STI Surveillance Research Center, and WHO Collaborating center for HIV surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.

Hamid Pakmanesh (H)

Department of Urology, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.

Moghaddameh Mirzaee (M)

Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.

Azam Bazrafshan (A)

Kerman Population-based Cancer Registry (KPBCR), Deputy of Health, Kerman University of Medical Sciences, Kerman, Iran.

Mehdi Shafiei Bafti (M)

Department of Communicable Diseases, Kerman University of Medical Sciences, Kerman, Iran.

Armita Shahesmaeili (A)

HIV/STI Surveillance Research Center, and WHO Collaborating center for HIV surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH